CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-8.4%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.07B
AUM Growth
-$732M
(-15%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
681
New
46
Increased
261
Reduced
260
Closed
64
Top Buys
| 1 |
Nike
NKE
|
+$34.7M |
| 2 |
Starbucks
SBUX
|
+$27.3M |
| 3 |
Procter & Gamble
PG
|
+$26M |
| 4 |
McKesson
MCK
|
+$24M |
| 5 |
NVIDIA
NVDA
|
+$23.9M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$109M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$30.4M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$23.6M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$20.3M |
| 5 |
Kellanova
K
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 28.72% |
| 2 | Financials | 13.85% |
| 3 | Technology | 10.07% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cencora
COR
$57.9B
| $2.92M | 0.07% |
30,704
+1,478
| +5% | +$140K |
|
277
Danaher
DHR
$139B
| $2.91M | 0.07% |
50,778
-2,818
| -5% | -$161K |
|
|
PTLA
278
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.9M | 0.07% |
68,100
-20,900
| -23% | -$891K |
|
|
NBL
279
DELISTED
Noble Energy, Inc.
NBL
| $2.89M | 0.07% |
95,751
-58,829
| -38% | -$1.78M |
|
|
CASC
280
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.87M | 0.07% |
+174,500
| New | +$2.87M |
|
281
Air Products & Chemicals
APD
$63.9B
| $2.87M | 0.07% |
24,272
+2,305
| +10% | +$272K |
|
282
Canadian National Railway
CNI
$58.2B
| $2.86M | 0.07% |
50,627
+1,901
| +4% | +$107K |
|
283
Scotiabank
BNS
$79.3B
| $2.86M | 0.07% |
67,346
+470
| +0.7% | +$19.9K |
|
284
Tractor Supply
TSCO
$31.3B
| $2.84M | 0.07% |
168,165
-42,080
| -20% | -$710K |
|
|
AKRX
285
DELISTED
Akorn, Inc.
AKRX
| $2.82M | 0.07% |
98,800
-19,200
| -16% | -$547K |
|
286
American Tower
AMT
$91.1B
| $2.81M | 0.07% |
31,900
+4,117
| +15% | +$362K |
|
|
SAGE
287
DELISTED
Sage Therapeutics
SAGE
| $2.8M | 0.07% |
66,200
-5,800
| -8% | -$245K |
|
288
Insmed
INSM
$31.1B
| $2.76M | 0.07% |
148,800
-17,200
| -10% | -$319K |
|
289
Simon Property Group
SPG
$58.6B
| $2.71M | 0.07% |
14,771
+912
| +7% | +$168K |
|
290
Lumen
LUMN
$5.78B
| $2.65M | 0.06% |
105,307
+3,281
| +3% | +$82.4K |
|
291
TG Therapeutics
TGTX
$5.08B
| $2.63M | 0.06% |
261,200
-38,800
| -13% | -$391K |
|
292
NetApp
NTAP
$24.6B
| $2.58M | 0.06% |
87,282
+69,791
| +399% | +$2.07M |
|
293
DuPont de Nemours
DD
$32.1B
| $2.56M | 0.06% |
29,901
+1,458
| +5% | +$125K |
|
294
Ovintiv
OVV
$10.7B
| $2.55M | 0.06% |
79,452
+17,128
| +27% | +$549K |
|
295
Ultragenyx Pharmaceutical
RARE
$3.04B
| $2.53M | 0.06% |
26,280
-9,720
| -27% | -$936K |
|
296
Sun Life Financial
SLF
$32.9B
| $2.51M | 0.06% |
78,301
+63,107
| +415% | +$2.03M |
|
|
XLRN
297
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.51M | 0.06% |
100,800
+800
| +0.8% | +$19.9K |
|
|
BHI
298
DELISTED
Baker Hughes
BHI
| $2.49M | 0.06% |
47,887
-14,048
| -23% | -$731K |
|
299
General Mills
GIS
$26.9B
| $2.44M | 0.06% |
43,375
+3,351
| +8% | +$188K |
|
300
Walmart
WMT
$816B
| $2.41M | 0.06% |
111,282
-28,905
| -21% | -$625K |
|